CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
StemCell2MAX is a biotechnology start-up focused on multiplying blood stem cells to meet the high demand for transplants and research. Their proprietary solution significantly enhances cell quality, aiming to serve hospitals, cord blood banks, and researchers in the clinical and research markets.
StemCell2MAX is a biotechnology start-up that owns a proprietary solution for multiplying blood stem cells.
Blood stem cells are required for both research and blood cancer treatment, but are scarce resulting in limited transplants (34% of patients do not find a donor), patient death (6-15%) and limitations at research level (12.500 groups lack cells for their studies).
StemCell2MAX addresses this enormous demand from patients, cord blood banks, hospitals and researchers in an estimated €3 billi…
GROWINGFORMULA LDA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
